Your session is about to expire
← Back to Search
Diagnostic Test
CT Perfusion for Coma and Cardiac Arrest (CANCCAP Trial)
N/A
Waitlist Available
Led By Jai Shankar, MD FRCPC
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 hours
Awards & highlights
CANCCAP Trial Summary
This trial is designed to validate CTP as a reliable predictor of neurological outcome at hospital discharge in CCAP.
Eligible Conditions
- Cardiac Arrest
CANCCAP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 48 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
To validate CTP, relative to the reference standard of initial clinical assessment, for predicting poor neurological outcome (≥4 on modified Rankin scale) at hospital discharge in CCAP.
CANCCAP Trial Design
1Treatment groups
Experimental Treatment
Group I: Comatose cardiac arrest patientsExperimental Treatment1 Intervention
Comatose cardiac arrest patients will be undergoing CT perfusion test
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CT Perfusion
2021
N/A
~300
Find a Location
Who is running the clinical trial?
University of ManitobaLead Sponsor
595 Previous Clinical Trials
199,390 Total Patients Enrolled
2 Trials studying Cardiac Arrest
850 Patients Enrolled for Cardiac Arrest
Manitoba Medical Service FoundationOTHER
18 Previous Clinical Trials
975 Total Patients Enrolled
Jai Shankar, MD FRCPCPrincipal InvestigatorUniversity of Manitoba
1 Previous Clinical Trials
200 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a severe stage of chronic kidney disease with a very low estimated glomerular filtration rate (eGFR).You have had an allergic reaction to CT scan dye in the past.Adults who are in a coma after experiencing a cardiac arrest outside of a hospital.Your doctor is planning to use special temperature management treatment after a cardiac arrest.
Research Study Groups:
This trial has the following groups:- Group 1: Comatose cardiac arrest patients
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any current openings in this biomedical experiment?
"The information available on clinicaltrials.gov confirms that recruitment for this trial remains open, with the original post dating back to May 1st 2021 and the most recent update coming in June 9th 2022."
Answered by AI
To what extent have participants engaged in this clinical experiment?
"Affirmative. Clinicaltrials.gov indicates that this medical trial has been recruiting patients since May 1st 2021, with the latest update on June 9th 2022. A total of 90 participants must be enrolled from a single site to complete the study."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger